An antitumor agent of beta-cyclodextrin-modified titanocene complex: synthesis and characterization.

Chang-Sheng Lu,Yang Zou,Jing-Li Xie,Zhao-Ping Ni,Hui-Zheng Zhu,Qing-Jin Meng,Yuan-Gen Yao
DOI: https://doi.org/10.1248/cpb.51.864
2003-01-01
Abstract:The complex of a derivative of P-cyclodextrin, that is mono[6-deoxy-6-(2-butenedinitrile-2,3-dimercapto sodium salt)]-beta-eyelodextrin (6-mnt-beta-CD), with titanocene (titanocene di[mono [6-deoxy-6-(2-butenedinitrile-2,3-dimercapto)]-beta-cyclodextrin], Cp2Ti[6-mnt-beta-CD](2)) has been synthesized and characterized by IR spectroscopy, UV spectroscopy, elemental analysis, thermogravimetry, H-1- and C-13-NMR spectroscopy. The stoichiometry of the target molecule was determined by H-1-NMR spectroscopy and elemental analysis.
What problem does this paper attempt to address?